Aratana Therapeutics, Inc.Aratana Therapeutics, Inc. • October 16th, 2013 • Pharmaceutical preparations
Reference is made to (1) that certain Agreement and Plan of Merger, dated as of the date hereof (the “Merger Agreement”), by and among Aratana Therapeutics, Inc., a Delaware corporation (“Parent”), Jayhawk Acquisition Corporation, a Delaware corporation and direct wholly-owned subsidiary of Parent, Vet Therapeutics, Inc., a Delaware corporation (the “Company”), and, with respect to Article VIII only of the Merger Agreement, Jeffrey Miles, as Stockholders’ Representative and (2) that certain Share Purchase Agreement, dated on or about the date hereof (the “Share Purchase Agreement”), by and among Parent and each of those persons and entities listed on the Schedule of Purchasers attached as Exhibit A thereto. Capitalized terms not otherwise defined herein shall have the meaning ascribed such terms in the Merger Agreement.
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT (INDICATED BY ASTERISKS) HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. FIRST AMENDMENT AND JOINDER TO...Loan and Security Agreement • October 16th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations
This First Amendment and Joinder to Loan and Security Agreement (this “First Amendment and Joinder”), dated as of October 11, 2013, is executed and delivered by VET THERAPEUTICS, INC., a Delaware corporation (“New Borrower”), ARATANA THERAPEUTICS, INC. (“Borrower”), and SQUARE 1 BANK (“Bank”). Capitalized terms used herein but not otherwise defined herein shall have the meanings ascribed to those terms in the Loan Agreement (as defined below).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT (INDICATED BY ASTERISKS) HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. AGREEMENT AND PLAN OF MERGER BY...Agreement and Plan of Merger • October 16th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of October 13, 2013, by and among Aratana Therapeutics, Inc., a Delaware corporation (“Parent”), Jayhawk Acquisition Corporation, a Delaware corporation and direct wholly-owned subsidiary of Parent (“Merger Sub”), and Vet Therapeutics, Inc., a Delaware corporation (the “Company”), and, with respect to Article VIII only, Jeffrey Miles, as Stockholders’ Representative (as defined in Section 8.5(a)).
SHARE PURCHASE AGREEMENTShare Purchase Agreement • October 16th, 2013 • Aratana Therapeutics, Inc. • Pharmaceutical preparations • New York
Have you or your organization had any position, office or other material relationship within the past three years with the Company or its affiliates?
